Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.
about
Genetic variants in TNFa, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthmaRed meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control studyAllellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and womenRelationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancerDeterminants of the interindividual variability in response to antiplatelet drugsPolymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approachAspirin resistance: a revival of platelet aggregation tests?A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian populationCyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) studyGenetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer riskExploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicityModulation of COX-2 expression in peripheral blood cells by increased intake of fruit and vegetables?Use of genetic data to guide therapy in arterial disease.A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer.Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran.Functional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women.Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control studyThe functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's diseaseGallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes.-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study.Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levelsGenetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.Interactions between meat intake and genetic variation in relation to colorectal cancer.The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapyInteraction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskCOX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.Not all smokers die young: a model for hidden heterogeneity within the human populationAssociation between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study.PharmGKB summary: very important pharmacogene information for PTGS2.Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesisPolymorphisms associated with asthma are inversely related to glioblastoma multiforme.Association of cyclooxygenase-2 genetic variant with cardiovascular disease.Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.
P2860
Q23910400-9B5E2348-AFB4-4AE5-93FC-B3F076DCD0C4Q24614203-5B47D9DE-6C71-4FDF-84B5-D70D84C8F92CQ25255846-7DF706AC-BFE2-438F-8608-F66C7BC26CA7Q25257421-CA3AA187-7879-4DB8-9793-568E47FF7A69Q25257445-57EDE4BA-EF2F-4E6C-A9EA-45C0629CFC64Q28168820-48410819-8445-438E-B88A-3A9C3D63A8E0Q28187591-5BEDDB95-1039-4144-B0A3-BB5EE192F1B7Q28199903-B4228E1C-E56E-43EB-B902-382ED1EE3AD5Q28208759-ECD5694C-5B28-4C20-8118-05CE99F9D30BQ28210185-3B113BD1-8EEA-412E-9F89-86035CCEF00EQ28210322-6491507E-2787-4EA4-B8BE-9D3327F85AEEQ28213217-2BA96DE9-31F8-45DA-935C-0FA69A7F472DQ28218177-73155660-CF87-4F49-8293-E938AF218B02Q28218383-C094DDE2-173B-47AE-AE9B-4321B103B500Q30978916-F0A63B79-3EDC-4178-84D1-270C69AED5B1Q33394594-5F98B359-9F0D-470A-96A4-F2BBD0D405C3Q33596371-E75F8BEF-3DBF-48FA-9BBE-57D0FAC6DD12Q33600759-92B3263B-494B-4E7C-89D1-DA5E95FD90C8Q33682155-6627C51E-61B7-439A-B077-FC9CCF25B1D0Q33741123-17E1E762-C351-491E-BA77-E3AC77CC4969Q33760727-1AEE42BE-6403-499A-846F-D04436905CD6Q33808898-3CDB6456-CA48-4331-B2EC-4358B27285D2Q33869492-40BEDD8A-8326-4674-A745-BCAABE1AFCB2Q34096844-A1EDE1BF-5E70-47E8-AD93-9DA79157F200Q34104601-E49FF839-6AA0-4693-BB5B-B5DF56D0B849Q34253730-C1DDC661-1126-40DB-986F-ABF0F69BEED8Q34315488-FC8798E9-DA9D-4122-80C1-05BD484D4BCCQ34351250-4B8DFDA7-A622-4B13-81E9-023FE54DD901Q34664123-FA22CB0C-DC5E-4815-B6A7-C7BFE5FCC22DQ34689044-05B9E0B6-9584-43C8-84F3-B1753B0E47A6Q34794017-66384F31-B389-4CF1-B37F-CE739FB23051Q34984281-1BCF3097-E42E-432D-8AA8-5DFA622292F9Q35092632-3D25AB60-895C-413E-B0D1-5A668ECA61FCQ35097240-41634564-CD94-4C05-B66A-AB3FECDAC78BQ35120350-5A19183A-B981-4880-9342-F519E6660900Q35147941-1B48FD43-CF61-41E1-826E-192979226E5EQ35465562-ED8FDB7A-8A1C-4D9B-AF63-5A3B2E23D71BQ35570946-47E9E69D-7EC0-4C7F-8349-F9864FD869E6Q35608507-5870D382-6C87-4B69-85ED-CABF7405390DQ35621619-87A552B6-6F3E-4AEC-B7B2-A00A3964A934
P2860
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Common promoter variant in cyc ...... e-phase inflammatory response.
@en
type
label
Common promoter variant in cyc ...... e-phase inflammatory response.
@en
prefLabel
Common promoter variant in cyc ...... e-phase inflammatory response.
@en
P2093
P1476
Common promoter variant in cyc ...... te-phase inflammatory response
@en
P2093
Anastasia Papafili
David J Brull
Geoffrey J Laurent
Michael R Hill
Richard P Marshall
Steve E Humphries
P304
P356
10.1161/01.ATV.0000030340.80207.C5
P407
P577
2002-10-01T00:00:00Z